Pharmacoeconomic analysis of alogliptin use in the treatment of type 2 diabetes

• প্রধান লেখক: S. V. Nedogoda (লেখক), I. N. Sorokina (লেখক), A. S. Salasiuk (লেখক), V. O. Smirnov (লেখক)
• বিন্যাস: গ্রন্থ
• প্রকাশিত: Izdatelstvo OKI, 2018-05-01T00:00:00Z.
• বিষয়গুলি: article
• অনলাইন ব্যবহার করুন: Connect to this object online.

Aim of the study: Determine the validity of alogliptin choice in comparison with other DPP-4 inhibitors, available in Russia (saxagliptin, linagliptin, vildagliptin, sitagliptin) for add-on treatment in patients with inadequate glycemic control on metformin monotherapy, basing on pharmacoeconomic an...